Researchers from Nantong University developed a novel targeted drug delivery system using functionalized pillararenes for ...

An American College of Surgeons initiative reduced postoperative hospitalization among older adults with cancer, according to ...

A multicenter study led by researchers from the State Key Laboratory of Ophthalmology in China has characterized a distinct ...

Dec. 10, 2024 — In a single IV injection, a gene therapy targeting cBIN1 can reverse the effects of heart failure and restore heart function in a large animal model. The therapy increases the ...

Tempus AI, Inc. (NASDAQ:TEM) stock is trading higher on Thursday after the company announced a collaboration with the ...

When stage 4 pancreatic cancer progresses through metastasis to abdominal organs and potentially spreads to distant sites ...

The pharmaceutical landscape is undergoing a dramatic transformation. New modalities are reshaping what's possible in drug development, from monoclonal antibodies to RNA therapies, from small ...

Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, and Tempus, a technology company leading the adoption of AI to advance precision ...

Ares Management Corporation ("Ares"), a leading global alternative investment manager, announced today that Ares Credit funds served as the administrative agent on $300 million in incremental debt ...

Reno Orthopedic Center (ROC) proudly announces Nevada’s very first Opioid-Free Orthopedic Surgery Program.  This program sets ...

Background Treatment strategies for Crohn’s disease (CD) suppress diverse inflammatory pathways but many patients remain ...

Does hypnosis really alter the brain? Science says YES! New research reveals how hypnosis impacts brainwaves, relaxation, and ...